摘要
背景:发热在神经重症监护病人中很常见,与不良结局有关。急性脑损伤后的目标温度管理(TTM),即治疗低温或受控的正常体温已被研究为几十年的神经保护剂。与具有特定目标的药理学相反,TTM影响多种病理生理机制,主要被认为是减轻继发性脑损伤。从脑缺血或创伤性脑损伤的实验研究中获得最有希望的结果,显示低温对结构和功能结果的有益作用。 目的:本文系统综述文献的目的是提供关于TTM用于脑内出血(ICH)的临床前和临床资料的概述。将总结TTM对诱导和自发ICH后结构变化和功能结局的影响。 结果与讨论:在自发性ICH改善的动物模型中观察到低体温的积极影响,其中包括周围水肿,血脑屏障完整性,炎症和凝血酶诱导的损伤。然而,关于功能结果的结果是相冲突的。 TTM在人体自发性ICH后的效果很少。单中心观察性研究表明,轻度低体温降低了周围水肿,与良性结局相关。然而,迄今为止,在随机研究中尚未证实这些对死亡率和功能结局的有益影响。因此,非常期待正在进行的,前瞻性的随机对照试验的结果。
关键词: 脑损伤,体温过低,正常体温,周围水肿,自发性脑内出血,靶向温度管理,TTM。
图形摘要
Current Drug Targets
Title:Targeted Temperature Management in Spontaneous Intracerebral Hemorrhage: A Systematic Review
Volume: 18 Issue: 12
关键词: 脑损伤,体温过低,正常体温,周围水肿,自发性脑内出血,靶向温度管理,TTM。
摘要: Background: Fever is common in neurocritical care patients and is associated with poor outcome. Targeted temperature management (TTM), i.e. therapeutic hypothermia or controlled normothermia, after acute brain injury has been studied as a neuroprotectant for several decades. In contrast to pharmacological agents with specific targets TTM affects multiple pathophysiological mechanisms and is primarily thought to attenuate secondary brain injury. Most promising results have been obtained from experimental studies on cerebral ischemia or traumatic brain injury showing beneficial effects of hypothermia on structural and functional outcome.
Objective: The aim of this systematic review of the literature is to provide an overview on preclinical and clinical data on the use of TTM for intracerebral hemorrhage (ICH). The impact of TTM on structural changes and functional outcome after induced and spontaneous ICH will be summarized. Results and Discussion: A positive influence of hypothermia has been observed in animal models of spontaneous ICH improving, among others, perihematomal edema, blood-brain barrier integrity, inflammation and thrombin-induced injury. However, results regarding functional outcome are conflicting. Little data is available on the effect of TTM after spontaneous ICH in humans. Single-center observational studies have shown reduced perihematomal edema under mild hypothermia and an association with favorable outcome. However, these beneficial effects on mortality and functional outcome have not been confirmed in randomized studies so far. Thus, results from ongoing, prospective randomized-controlled trials are highly anticipated.Export Options
About this article
Cite this article as:
Targeted Temperature Management in Spontaneous Intracerebral Hemorrhage: A Systematic Review, Current Drug Targets 2017; 18 (12) . https://dx.doi.org/10.2174/1389450117666160703161511
DOI https://dx.doi.org/10.2174/1389450117666160703161511 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Meet Our Editor:
Current Pediatric Reviews Notch Signaling in the Central Nervous System with Special Reference to its Expression in Microglia
CNS & Neurological Disorders - Drug Targets Pharmacologic Treatment of Pulmonary Arterial Hypertension
Current Pharmaceutical Design Gliomas: Current Issues in Diagnosis and Treatment
Current Medical Imaging Therapeutic Targeting of TRPV1 by Resiniferatoxin, from Preclinical Studies to Clinical Trials
Current Topics in Medicinal Chemistry Recent Advances in Endocrine Metabolic Immune Disorders Drug Targeting: An Editorial Overview
Endocrine, Metabolic & Immune Disorders - Drug Targets Therapeutic Angiogenesis using Hepatocyte Growth Factor (HGF)
Current Gene Therapy The Delivery of Biologically Active (Therapeutic) Peptides and Proteins into Cells
Current Medicinal Chemistry Tau Truncation is a Productive Posttranslational Modification of Neurofibrillary Degeneration in Alzheimer’s Disease
Current Alzheimer Research Bv8-Prokineticins and their Receptors: Modulators of Pain
Current Pharmaceutical Biotechnology Monoclonal Antibodies in Rare Acquired Thrombotic Disorders: The Paradigms of Paroxysmal Nocturnal Hemoglobinuria, Thrombotic Thrombocytopenic Purpura and Central Retinal Vein Occlusion
Current Vascular Pharmacology Selective Divalent Copper Chelation for the Treatment of Diabetes Mellitus
Current Medicinal Chemistry Cognitive Impacts of Estrogen Treatment in Androgen-Deprived Males: What Needs to be Resolved
Current Neuropharmacology Early Brain Injury or Vasospasm? An Overview of Common Mechanisms
Current Drug Targets NADPH Oxidases and Inflammatory Bowel Disease
Current Medicinal Chemistry Restless Legs Syndrome in Children: A Review and Update on Pharmacological Options
Current Pharmaceutical Design “The Future Magic Bullet”: A Review of Pharmacological Activities of Ethyl Pyruvate and its Derivatives
Current Drug Therapy Therapeutic Potential of Erythropoietin in Retinal and Optic Nerve Diseases
CNS & Neurological Disorders - Drug Targets Driving Neural Stem Cells Towards a Desired Phenotype
Current Stem Cell Research & Therapy Sirtuins Family- Recent Development as a Drug Target for Aging, Metabolism, and Age Related Diseases
Current Drug Targets